Modeling Kinetic Interactions of Chemical Mixtures

Principles and Practice of Mixtures Toxicology

Volumn , Issue , 2010, Pages 125-157

  Campbell Jr , Jerry L ^a   Krishnan, Kannan ^b,c   Clewell III, Harvey J ^a   Andersen, Melvin E ^a  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Biotransformation; Metabolic rate constants; PBPK modeling; Pharmacokinetic behavior; Skin permeability constant; Tissue:blood partition coefficient

Indexed keywords

EID: 84886459652     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527630196.ch5     Document Type: Chapter

References (92)

1. Teorell, T. (1937) Kinetics of distribution of substances administered to the body. I. The extravascular modes of administration. Arch. Int. Pharmacodyn., 57, 205-225.
2. Teorell, T. (1937) Kinetics of distribution of substances administered to the body. II. The intravascular modes of administration. Arch. Int. Pharmacodyn., 57, 226-240.
3. Andersen, M.E., Clewell, H.J., and Frederick, C.B. (1995) Applying simulation modeling to problems in toxicology and risk assessment - a short perspective. Toxicol. Appl. Pharmacol., 133, 181-187.
4. Andersen, M.E. (1981) Saturable metabolism and its relation to toxicity. Crit. Rev. Toxicol., 9, 105-150.
5. Andersen, M.E., Clewell, H.J., and Krishnan, K. (1995) Tissue dosimetry, pharmacokinetic modeling, and interspecies scaling factors. Risk Anal., 15, 533-537.
6. O'Flaherty, E.J. (1987) Modeling: An introduction. In: (2nd Edn. ed.), Pharmacokinetics in Risk Assessment. Drinking Water and Health, Volume. 8. NationalAcademy Press, Washington DC, pp. 27-35.
7. Clewell, R.A. and Clewell, H.J. (2008) Development and specification of physiologically based pharmacokinetic models for use in risk assessment. Reg. Toxicol. Pharmacol., 50, 129-143.
8. Ramsey, J.C. and Andersen, M.E. (1984) A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol., 73, 159-175.
9. Reddy, M.B., Yang, R.S.H., Clewell, H.J. III, and Andersen, M.E. (2005) Physiologically Based Pharmacokinetic Modeling: Science and Applications, John Wiley & Sons, Inc., Hoboken, New Jersey.
10. McDougai, J.N., Jepson, G.W., Clewell, H.J. III, MacNaughton, M.G., and Andersen, M.E. (1986) A physiological pharmacokinetic model for dermal absorption of vapors in the rat. Toxicol. Appl. Phamacol., 85, 286-294.
11. Fisher, J.W., Whittaker, T.A., Taylor, D.H., Clewell, H.J. III, and Andersen, M.E. (1990) Physiologically based pharmacokinetic modeling of the pregnant rat: multiroute exposure model for trichloroethylene and trichloroacetic acid. Toxicol. Appl. Pharmacol., 99, 395-414.
12. Travis, C.C. and Bowers, J.C. (1989) Protein binding of benzene under ambient exposure conditions. Toxicol. Ind. Health, 5, 1017-1024.
13. Krishnan, K., Gargas, M.L., Fennell, T.R., and Andersen, M.E. (1992) A physiologically based description of ethylene oxide dosimetry in the rat. Toxicol. Ind. Health, 8, 121-140.
14. Fennell, T.R., Sumner, S., and Walker, V.E. (1992) A model for the simulation of the formation and degradation of hemoglobin adducts. Cancer Epidemiol. Biomark. Prev., 1, 213-219.
15. Rowland, M. (1985) Physiological pharmacokinetic models and interanimal species scaling. Pharmacol. Ther., 29, 49-68.
16. Levy, G. (1980) Effect of plasma protein binding on renal clearance of drugs. 1. Pharmaceut. Sci., 69, 482-483.
17. Wesson, L.G. (1954) A theoretical analysis of urea excretion by the mammalian kidney. Am. J. Physiol., 179, 364-371.
18. Hall, S. and Rowland, M. (1983) Relationship between renal clearance, protein binding and urine flow for digitoxin, a compound of low clearance in isolated perfused rat kidney. J. Pharmacol. Exp. Ther., 227, 174-180.
19. Tangliu, D.D., Tozer, T.N., and Riegelman, S. (1983) Dependence of renal clearance on urine flow: a mathematical model and its applications. J. Pharmaceut. Sci., 72, 154-158.
20. Caster, W.O., Poncelet, J., Simon, A.B., and Armstrong, W.D. (1956) Tissue weights of the rat. 1. Normal values determined by dissection and chemical methods. Proc. Soc. Exp. Biol. Med., 91, 122-126.
21. International Commission on Radiation Protection (1975) Report of the Task Group on Reference Man, ICRP Publication No. 23, Pergamon Press, New York.
22. Delp, M.D., Manning, R.O., Bruckner, J.V., and Armstrong, R.B. (1991) Distribution of cardiac output during diurnal changes of activity in rats. Am. J. Physiol., 261, H1487-H1493.
23. Arms, A.D. and Travis, C.C. (1988) Reference Physiological Parameters in Pharmacokinetic Modeling. NTIS PB 88-196019, Office of Health and Environmental Assessment, U.S. Environmental Protection Agency, Washington, D.C.
24. Chen, H.S.G. and Gross, J.F. (1979) Estimation of tissue to plasma partition coefficients used in physiological pharmacokinetic models. Pharmacokinet. Biopharmaceut., 7, 117-125.
25. Lin, J.H., Sugiyama, Y., Awazu, S., and Hanano, M. (1982) In vitro and in vivo evaluation of the tissue to blood partition coefficients for physiological pharmacokinetic models. I. Pharmacokinet. Biophamaceut., 10, 637-647.
26. Sato, A. and Nakajima, T. (1979) Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and air. Br. J. Ind. Med., 36, 231-234.
27. Gargas, M.L., Burgess, R.J., Voisard, D.J., Cason, G.H., and Andersen, M.E. (1989) Partition coefficients of low molecular weight volatile compounds in various liquids and tissues. Toxicol. Appl. Pharmacol., 98, 87-99.
28. Sato, H., Sugiyama, Y., Sawada, Y., Iga, T., and Hanano, M. (1987) Physiologically-based pharmacokinetics of radioiodinated human endorphin in rats: An application of the i capillary membrane-limited model. Drug. Metab. Disp., 15, 540-550.
29. McDougal, J.N., Jepson, G.W., Clewell, H.J. III, and Andersen, M.E. (1985) Dermal absorption of dihalomethane vapors. Toxicol. Appl. Pharmacol., 79, 150-158.
30. Gargas, M.L. (1990) An exhaled breath chamber system for assessing rats of metabolism and rats of gastrointestinal absorption with volatile chemicals. J. Am. Coll. Toxicol., 9, 447-453.
31. Mauderly, J.L. (1990) Measurement of respiration and respiratory responses during inhalation exposures. J. Am. Coll. Toxicol., 9, 397-406.
32. Gargas, M.L., Andersen, M.E., and Clewell, H.J. III (1986) A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicol. Appl. Pharmacol., 86, 341-352.
33. Gargas, M.L. and Andersen, M.E. (1989) Determining the kinetic constants of chlorinated ethane metabolism in the rat from rates of exhalation. Toxicol. Appl. Pharmacol., 99, 344-353.
34. Deitz, F.K., Rodriguez-Giaxoia, M., Traiger, G.J., Stella, V.J., and Himmelstein, K.J. (1981) Pharmacokinetics of 2-butanol and its metabolites in the rat. Pharmacokinet. Biopharmaceut., 9, 553-576.
35. Krishnan, K. and Andersen, M.E. (1993) In vitro toxicology and risk assessment, in Alternative Methods in Toxicology, vol. 10 (ed. A.M. Goldberg), Liebert, New York, pp. 113-124.
36. Lin, J.H., Hayashi, M., Awazu, S., and Hanano, M. (1978) Correlation between in vitro and in vivo drug metabolism rate: oxidation of ethoxybenzamide in rat. J. Pharmacokinet. Biophamaceut., 6, 327-337.
37. Lin, J.H., Sugiyama, Y., Awazu, S., and Hanano, M. (1982) Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological data. J. Phamacokinet. Biophamaceut., 10, 649-661.
38. Sugita, O., Sawada, Y., Sugiyama, Y., Iga, T., and Hanano, M. (1982) Physiologically based pharmacokinetics of drug-drug interaction: a study of tolubutamidesulfonamide interaction in rats. 1. Pharmacokinet. Biopharmaceut., 10, 297-312.
39. Sato, A. and Nakajima, T. (1979) A vial equilibration method to evaluate the drug metabolizing enzyme activity for volatile hydrocarbons. Toxicol. Appl. Pharmacol., 47, 41-46.
40. Sato, H., Sugiyama, Y., Miyauchi, S., Sawada, Y., Iga, T., and Hanano, M. (1986) A simulation i study on the effect of a uniform diffusional barrier across hepatocytes on drug metabolism ! by evenly or unevenly distributed unienzyme in the liver. J. Pharmaceut. Sci., 75, 3-8.
41. Reitz, R.H., Mendrala, A.L., Park, C.N., Andersen, M.E., and Guengerich, F.P. (1988) Incorporation of in vitro enzymatic data into the physiologicallybased pharmacokinetic (PBPK) model for methylene chloride: implications for risk assessment. Toxicol. Lett., 43, 97-116.
42. Gearhart, J.M., Jepson, G.W., Clewell, H.J. III, Andersen, M.E., and Conolly, R.B. (1990) Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropyl fluorophosphate. Toxicol. Appl. Pharmacol., 106, 295-310.
43. Sultatos, L.G. (1990) A physiologically based pharmacokinetic model of parathion based on chemical specific parameters determined in vitro. J. Am. Coll. Toxicol., 9, 611-617.
44. Carfagna, M.A. and Kedderis, G.L. (1992) Isolated hepatocytes as in vitro models for the biotransformation and toxicity of chemicals in vivo. CIIT Activities, 12 (9-10), 1-6.
45. Clewell, H.J. III, and Andersen, M.E. (1987) Dose, species, and route extrapolations using physiologically based pharmacokinetic models. Drink. Water Health, 8, 159-184.
46. Krishnan, K. and Andersen, M.E. (1994) Physiologically-based pharmacokinetic modeling in toxicology, in Principles and Methods of Toxicology, 3rd edn (ed. A.W. Hayes), Raven Press, New York, pp. 149-188.
47. Andersen, M.E., Clewell, H.J., III, Gargas, M.L., Smith, F.A., and Reitz, R.H. (1987) Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol., 87, 185-205.
48. Segel, I.H. (1974) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, John Wiley & Sons, Inc., New York.
49. Kuhy, S.A. (1991) A Study of Enzymes, vol. I, CRC Press, Boca Raton, Florida, pp. 20-26.
50. Cunningham, E.B. (1978) Biochemical Mechanisms of Metabolism, McGraw Hill, New York.
51. Luecke, R.H. and Wosilait, W.D. (1986) Estimation of drug binding parameters. Pharmacokinet. Biopharmaceut., 14, 65-78.
52. Wosilait, W.D. and Luecke, R.H. (1990) Displacement interactions resulting from competition for binding sites on proteins, in Toxic Interactions (eds R. Goldstein, W.R. Hewitt, and J. Hook), Academic Press, New York, pp. 115-148.
53. Sato, A. and Nakajima, T. (1979) Dosedependent metabolic interaction between benzene and toluene in vivo and in vitro. Toxicol. Appl. Pharmacol., 48, 249-256.
54. Krishnan, K. and Brodeur, J. (1991) Toxicological consequences of combined exposure to environmental pollutants. Arch. Complex Environ. Stud., 3 (3), 1-106.
55. Clewell, H.J., III, and Andersen, M.E. (1985) Risk assessment extrapolations and physiological modeling. Toxicol. Ind. Health, 1, 111-131.
56. Andersen, M.E., Gargas, M.L., Clewell, H.J. III, and Severyn, K.M. (1987) Quantitative evaluation of the metabolic interaction between trichloroethylene and 1, l-dichloroethylene in vivo using gas uptake methods. Toxicol. Appl. Pharmacol., 89, 149-157.
57. Purcell, K.J., Cason, G.H., Gargas, M.L., Andersen, M.E., and Travis, C.C. (1990) In vivo metabolic interactions of benzene and toluene. Toxicol. Lett., 52, 141-152.
58. Haddad, S., Tardif, R., Charest-Tardif, G., and Krishnan, K. (1999) Physiological modeling of the toxicokinetic interactions in a quaternary mixture of aromatic hydrocarbons. Toxicol. Appl. Pharmacol., 161, 249-257.
59. Thakore, K.N., Gargas, M.L., Andersen, M.E., and Mehendale, H.M. (1991) PBPK derived metabolic constants, hepatotoxicity, and lethality of BrCCl3 in rats pretreated with chlordecone, phenobarbital or mirex. Toxicol. Appl. Pharmacol., 109, 514-528.
60. Mehendale, H.M. (1991) Role of hepatocellular regeneration and References j155 hepatolobular healing in the final outcome of liver injury: a two stage model of toxicity. Biochem. Pharmacol., 42, 1155-1162.
61. Sato, A., Endoh, K., Kaneko, T., and Johanson, G. (1991) Effects of consumption of ethanol on the biological monitoring of exposure to organic solvent vapor: a simulation study with trichloroethylene. Br. J. Ind. Med., 48, 548-556.
62. Westerfeld, W.W., Schulman, M.P., and Syracuse, N.Y. (1959) Metabolism and clearance rate of alcohol. J. Am. Med. Assoc., 170, 197-203.
63. Fernandez, J.G., Droz, P.O., Humbert, B.E., and Capers, J.R. (1977) Trichloroethylene exposure: simulation of uptake, excretion and metabolism using a mathematical model. Br. J. Ind. Med., 34, 43-55.
64. Sato, A., Nakajima, T., and Koyama, Y. (1981) Dose-related effects of a single dose of ethanol on the metabolism of some aromatic and chlorinated hydrocarbons. Toxicol. Appl. Pharmacol., 60, 8-15.
65. Koizumi, A. (1989) Potential of physiological pharmacokinetics to amalgamate kinetic data of trichloroethylene and tetrachloroethylene obtained in rats and man. Br. J. Ind. Med., 46, 239-249.
66. Tardif, R., Lapare, S., Krishnan, K., and Brodeur, J. (1993) Physiologically based modeling of the toxicokinetic interaction between m-xylene and toluene. Toxicol. Appl. Phamacol., 120, 266-273.
67. Tardif, R., Lapar, S., Plaa, G.L., and Brodeur, J. (1991) Effect of simultaneous exposure to toluene and xylene on their respective biological exposure indices in humans. Int. Arch. Occup. Environ. Health, 63, 279-284.
68. Matsumura, F. (1975) Metabolism of carbamate insecticides, in Toxicology of Insecticides (ed. F. Matsumura), Plenum Press, New York, pp. 228-239.
69. Chambers, H.W. (1992) Organophosphorus compounds: an overview, in Organophosphates: Chemistry, Fate, and Effects (eds J.E. Chambersand P.E. Levi), Academic Press, San Diego, pp. 3-17.
70. Timchalk, C., Nolan, R.J., Mendrala, A.L., Dittenber, D.A., Brzak, K.A., and Mattsson, J.L. (2002) A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. Toxicol. Sci., 66, 34-53.
71. Nong, A., Tan, Y.M., Krolski, M.E., Wang, J. Lunchick, C., Conolly, R.B., and Clewell, H.J. 3rd. (2008) Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition. J. Toxicol. Environ. Health A. 71, 413-426.
72. Tardif, R., Charest-Tardif, G., Brodeur, J., and Krishnan, K. (1997) Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans. Toxicol. Appl. Pharmacol., 144, 120-134.
73. Haddad, S., Charest-Tardif, G., Tardif, R., and Krishnan, K. (2000) Validation of a physiological modeling framework for simulating the toxicokinetics of chemicals in mixtures. Toxicol. Appl. Pharmacol., 167, 199-209.
74. Haddad, S., Beliveau, M., Tardif, R., and Krishnan, K. (2001) A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures. Toxicol. Sci., 63, 125-131.
75. Krishnan, K., Haddad, S., Beliveau, M., and Tardif, R. (2002) Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixtures. Environ. Health Perspect., 110 (SUPPL. 6), 989-994.
76. Toftgard, R. and Nilsen, O.G. (1982) Effects of xylene and xylene isomers on cytochrome P-450 and in vitro enzymatic activities in rat liver, kidney and lung. Toxicology, 23, 197-212.
77. Guengerich, F.P., Kim, D.H., and Iwasaki, M. (1991) Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol., 4, 168-179.
78. Liira, J., Elovaara, E., Raunio, H., Riihimaki, V., and Engstrom, K. (1991) Metabolic interaction and disposition of 156j 5 Modeling Kinetic Interactions of Chemical Mixtures methyl ethyl ketone andm-xylene in rats at single and repeated inhalation exposures. Xenobiotica, 21, 53-63.
79. Nakajima, T., Wang, R.S., Elovaara, E., Park, S.S., Gelboin, H.V., Hietanen, E., and Vainio, H. (1991) Monoclonal antibody-directed characterization of cytochrome P450 isozymes responsible for toluene metabolism in rat liver. Biochem. Pharmacol., 41, 395-404.
80. Tassaneeyakul, W., Birkett, D.J., Edwards, J.W., Veronese, M.E., Tukey, R.H., and Miners, J.O. (1996) Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene. J. Pharmacol. Exp. Ther., 276, 101-108.
81. Dobrev, I.D., Andersen, M.E., and Yang, R.S. (2001) Assessing interaction thresholds for trichloroethylene in combination with tetrachloroethylene and 1,1,1-trichloroethane using gas uptake studies and PBPK modeling. Arch. Toxicol., 75, 134-144.
82. Dobrev, I.D., Andersen, M.E., and Yang, R.S. (2002) In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane. Environ. Health Perspect., 110, 1031-1039.
83. Dennison, J.E., Andersen, M.E., and Yang, R.S. (2003) Characterization of the pharmacokinetics of gasoline using PBPK modeling with a complex mixtures chemical lumping approach. Inhal. Toxicol., 15, 961-986.
84. Dennison, J.E., Andersen, M.E., Clewell, H.J., and Yang, R.S. (2004) Development of a physiologically based pharmacokinetic model for volatile fractions of gasoline using chemical lumping analysis. Environ. Sci. Technol., 38, 5674-5681.
85. Saito, F.U., Kocsis, J.J., and Snyder, R. (1973) Effect of benzene on hepatic drug metabolism and ultrastructure. Toxicol. Appl. Pharmacol., 26, 209-217.
86. Debets, F.M., Strik, J.J., and Olie, K. (1980) Effects of pentachlorophenol on rat liver changes induced by hexachlorobenzene, with special reference to porphyria and alterations in mixed function oxygenases. Toxicology, 15, 181-195.
87. Andersen, M.E. and Clewell, H.J. (1983) Pharmacokinetic interaction of mixtures. Proceedings of the Fourteenth Annual Conference on Environmental Toxicology, AFAMRL-TR-83-099, Dayton, Ohio, pp. 226-238.
88. Gilmour, S.K., Kalf, G.F., and Snyder, R. (1986) Comparison of the metabolism and benzene and its metabolite phenol in rat liver microsomes. Adv. Exp. Med. Biol., 197, 223-235.
89. Baker, T. and Rickert, D. (1981) Dosedependent uptake, distribution and elimination of inhaled n-hexane in the Fischer-344 rat. Toxicol. Appl. Pharmacol., 61, 414-422.
90. Campbell, J.L. Jr.and Fisher, J.W. (2007) A PBPK modeling assessment of the competitive metabolic interactions of JP-8 vapor with two constituents, m-xylene and ethylbenzene. Inhal. Toxicol., 19, 265-273.
91. Gordon, C.J., Herr, D.W., Gennings, C., Graff, J.E., McMurray, M., Stork, L., Coffey, T., Hamm, A., and Mack, C.M. (2006) Thermoregulatory response to an organophosphate and carbamate insecticide mixture: testing the assumption of dose-additivity. Toxicology, 217 (1), 1-13.
92. Krishnan, K., Clewell, H.J. III, and Andersen, M.E. (1994) Physiologicallybased pharmacokinetic analysis of simple mixtures. Environ. Health Perspect., 102 (SUPPL. 9), 151-155.